Embody vs bmiMD — Cost, meds, shipping and commitment compared
Quick verdict: Embody is the cheaper, no-frills option with compounded semaglutide from $69/month and fast 1–2 day free shipping; bmiMD focuses on tirzepatide with multi-month pricing as low as $139/month and 24/7 clinician access. This comparison covers pricing, medication selection, shipping and subscription commitments to help you decide between Embody vs bmiMD.
See Embody pricing and options
What each provider sells and who they target
Embody advertises compounded semaglutide at $69/month (reduced from $299) and compounded tirzepatide at $119/month, positioning itself for cost-driven patients who want a straightforward telehealth prescription model with no membership. bmiMD offers compounded tirzepatide only, with month-to-month and multi-month plans that reduce the monthly equivalent to as low as $139/month for a 12-month plan; bmiMD highlights clinician access and subscription options.
Five key differences: price, meds, shipping speed, commitments, and clinician access
1) Price and billing structure
Embody: Starting price shown is $69/month for compounded semaglutide and $119/month for compounded tirzepatide, described as flat locked-in monthly pricing and a limited-time $69 semaglutide offer. Final pricing may vary based on dose and clinician recommendation. bmiMD: Tirzepatide pricing varies by term: $179/month month-to-month; $159/month for three months; $149/month for six months; and $139/month for a 12-month plan. bmiMD emphasizes lower long-term monthly equivalents but notes the lowest price requires a 12-month commitment and that total prepaid charge should be confirmed.
2) Medication selection and formulation
Embody lists both compounded semaglutide and compounded tirzepatide. bmiMD lists compounded tirzepatide (GLP-1/GIP) as its offering. Both providers state their compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.
3) Shipping and turnaround
Embody advertises free shipping with delivery in 1–2 days after clinician approval. bmiMD also offers free subscription shipping and reports quick turnaround and reliable delivery, but the explicit 1–2 day claim is only stated for Embody.
4) Commitment, cancellations, and refunds
Embody markets no monthly membership and the ability to cancel anytime with no long-term commitment. bmiMD provides multiple billing terms with a 100% risk-free refundable note if a patient is not eligible for the program; however, bmiMD’s lowest monthly rate requires a 12-month commitment and customers should confirm total prepaid charges before enrolling.
5) Clinician access and service features
Embody includes telemed visits and a licensed provider review handled online, with 24/7 support access for dosing and side-effect questions noted. bmiMD highlights 24/7 clinician access as a feature and confirms medication preparation in state-licensed pharmacies and independent verification in labs for its compounded tirzepatide.
Comparison table
| Criteria | Embody | bmiMD |
|---|---|---|
| Starting price | $69/month semaglutide; $119/month tirzepatide | $179/month month-to-month; down to $139/month for 12-month plan |
| Medications offered | Compounded semaglutide and compounded tirzepatide | Compounded tirzepatide (GLP-1/GIP) |
| Shipping | Free; arrives in 1–2 days after approval | Free subscription shipping; quick turnaround reported |
| Commitment options | No monthly membership; cancel anytime | 1, 3, 6, 12 month billing options; lowest monthly requires 12-month commitment |
| Clinician access | Licensed provider review online; 24/7 support for dosing and side effects | 24/7 clinician access; state-licensed pharmacy preparation and lab verification |
Safety and regulatory note
Both Embody and bmiMD use compounded medications. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Embody’s site and bmiMD’s site each include this regulatory note.
How to choose between Embody vs bmiMD
If price and a fast, no-frills start are your priority, Embody advertises the lowest entry price with compounded semaglutide at $69/month and rapid 1–2 day free shipping after approval. If you want tirzepatide specifically and prefer multi-month plans with a lower long-term monthly equivalent plus 24/7 clinician access and stated pharmacy verification, bmiMD’s tiered billing down to $139/month for a 12-month plan may be preferable. Remember both use compounded medications and final pricing, availability, and eligibility are subject to clinician review and the live offer on each site.
Choose Embody if…
You want the lowest advertised entry price, need semaglutide availability at $69/month, fast 1–2 day free shipping, and no long-term commitment. Embody is positioned as a cost-driven, prescription-forward telehealth option.
Choose bmiMD if…
You plan to use tirzepatide and prefer multi-month pricing that lowers your monthly equivalent to as low as $139/month with subscription shipping and emphasis on clinician access and pharmacy verification. Confirm the required prepaid totals and eligibility before enrolling.